Rescue teams are racing against time following a massive reactor explosion at Sigachi Industries Pvt Ltd’s pharmaceutical plant in Pashamylaram, Sangareddy district, Telangana. The incident occurred on the morning of June 30, 2025, during a chemical drying operation when a reactor burst into flames, triggering an intense fire that engulfed the facility.
Immediately after the reactor blast, emergency personnel rushed to the scene. Authorities recovered 12 charred bodies (10 on-site and 2 who died en route to hospital), and at least 34 others were injured 12 critically. The injured are currently receiving treatment at local hospitals.
Prime Minister Narendra Modi expressed his condolences and announced a compensation package of ₹200,000 (~US $2,333) for each of the deceased and injured. Chief Minister Revanth Reddy and senior officials also visited the disaster site and affirmed all possible support.
Rescue operations continue amid precarious conditions. Authorities are uncertain if more victims remain trapped under smoldering rubble, and teams have begun DNA profiling to identify the charred remains. A forensic investigation is underway to determine the explosion’s cause preliminary indications suggest equipment failure during the reactor’s cleaning or drying cycle inside the spray-dryer unit.
Industrial Safety Under Spotlight after Reactor Blast incident
This catastrophic incident of Reactor Blast has once again spotlighted lapses in industrial safety at India’s expanding pharma hubs. Telangana hosts thousands of high-risk chemical and scroll production units in industrial zones such as Pashamylaram, Patancheru, and Jeedimetla. Experts stress the urgent need for stringent oversight, better maintenance routines, and upgraded safety protocols to prevent repeat tragedies.
As pressure mounts on regulators and company leaders, state and central authorities have ordered a comprehensive safety audit across Sigachi multiple plants. Meanwhile, the company has pledged full cooperation with investigators and support for affected families.
This devastating event not only highlights failures in safety enforcement but also underscores the human cost of neglect. Authorities swift action and transparency moving forward will be crucial in reshaping industrial safety standards across India’s vital pharmaceutical sector.
Grab more recent updates on our WhatsApp Channel
